T. Rowe Price Associates’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.17M | Sell |
|
|||||
|
2025
Q2 | $14.9M | Sell |
|
|||||
|
2025
Q1 | $17M | Sell |
|
|||||
|
2024
Q4 | $12.2M | Buy |
|
|||||
|
2024
Q3 | $30.9M | Buy |
|
|||||
|
2024
Q2 | $7.53M | Buy |
|
|||||
|
2024
Q1 | $3.87M | Sell |
|
|||||
|
2023
Q4 | $4.96M | Buy |
|
|||||
|
2023
Q3 | $4.07M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $390K | Buy |
|
|||||
|
2022
Q3 | $313K | Buy |
|
|||||
|
2022
Q2 | $223K | Buy |
|
|||||
|
2022
Q1 | $269K | Buy |
|
|||||
|
2021
Q4 | $361K | Buy |
|
|||||
|
2021
Q3 | $221K | Sell |
|
|||||
|
2021
Q2 | $214K | Sell |
|
|||||
|
2021
Q1 | $211K | Sell |
|
|||||
|
2020
Q4 | $7.16M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $30.2M | Sell |
|
|||||
|
2019
Q2 | $52.9M | Buy |
|
|||||
|
2019
Q1 | $57.7M | Buy |
|
|||||
|
2018
Q4 | $27.1M | Buy |
|
|||||
|
2018
Q3 | $38.6M | Sell |
|
|||||
|
2018
Q2 | $30.9M | Buy |
|
|||||
|
2018
Q1 | $21M | Buy |
|
|||||
|
2017
Q4 | $11M | Buy |
|